Taipei City – May 12, 2023
MATRIXLabs Medical and YC Biotech have announced the signing of a memorandum of cooperation, marking a significant step toward enhancing the production efficiency and market adoption of laparoscopic suture knotting devices.
MATRIXLabs Medical, a company dedicated to cutting-edge medical device development, has introduced an innovative laparoscopic suture knotting device that has been clinically proven to reduce knotting time by two-thirds. This patented technology has been validated through extensive research, with findings published in multiple medical journals.
Through this collaboration, YC Biotech, a biotechnology company specializing in new drug certification and contract manufacturing, will leverage its expertise in product development and market expansion to drive the widespread adoption of MATRIXLabs’ laparoscopic suture knotting devices.
This partnership represents a mutually beneficial collaboration. MATRIXLabs Medical will be able to accelerate product development and commercialization by utilizing YC Biotech’s industry expertise and resources. At the same time, YC Biotech will expand its presence in the biomedical sector by incorporating MATRIXLabs’ innovative technology into its comprehensive product portfolio.
Both companies are committed to revolutionizing the medical device industry, providing surgeons with more effective and efficient surgical tools while enhancing overall patient outcomes.
About MATRIXLabs Medical Inc.
MATRIXLabs Medical is a company dedicated to developing innovative medical devices, with particular expertise in the development of laparoscopic suture knotting devices. Their products have been proven to significantly reduce surgery time and improve medical efficiency.
About YC Biotech CO., LTD.
YC Biotech is a biotechnology company providing new drug certification and contract manufacturing services. Through collaborations with biotech companies across various fields, YC Biotech is committed to promoting innovation and development in biomedicine.